Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Point-of-care nanosensors for HIV diagnosis and monitoring, to be developed with £2 million award

Abstract:
A new device that will enable people living with HIV to monitor their own health and the effectiveness of their treatments will be developed thanks to a £2 million grant announced today.

Point-of-care nanosensors for HIV diagnosis and monitoring, to be developed with £2 million award

London | Posted on April 7th, 2009

The device will give sufferers a way to monitor the virus without having to visit a doctor so often. It will act as an early warning system to tell patients to seek medical help if the virus is resisting anti-retroviral treatments. It could also be of real benefit to doctors in developing countries who urgently need rapid and affordable ways to diagnose and monitor their patients.

Researchers from the London Centre for Nanotechnology, a joint venture between University College London (UCL) and Imperial College London, and their research partners have been awarded the Nanotechnology for Healthcare grant from the Engineering and Physical Sciences Research Council's Grand Challenge Competition.

LCN scientists and researchers from the UCL/MRC Centre for Medical Molecular Virology, the Royal Free Hampstead NHS Trust, Cambridge Medical Innovations, Sphere Medical Ltd and BionanoConsulting are working together on the project to develop the prototype hand-held device for clinical trials.

The research will bring biomedical engineers, physicists, chemists, virologists and clinicians together to create the device, which will work in a similar way to how diabetics check their insulin levels - where a hand-held machine analyses a finger prick of blood.

The device uses nanoscopic mechanical sensors, called microcantilever arrays to measure HIV and other protein markers that indicate a rise in the level of the virus and the body's response to it. UCL lead investigator Dr Rachel McKendry, Reader in Biomedical Nanoscience at the LCN, explains:

"The microcantilever arrays are each coated with substances that stick to the HIV and other proteins, which are markers associated with disease progression. Accommodating these markers causes the highly sensitive sensors to bend like a diving board and this bend indicates the level of virus in the body. We have used microcantilever arrays to investigate drug resistance in super bugs such as MRSA, and are excited by the opportunity to extend this approach to detecting HIV markers."

The device displays clear advice messages for patients on a screen. For example, patients could read the message "you are fine today" if levels of the virus are low or "have you scheduled a visit with your GP this week?" if the virus is flaring up. Investigator, Dr. Anna-Maria Goretti, an NHS consultant and co-investigator based at the Royal Free Hospital, says:

"If patients neglect to take their treatments or need prompting to see their GP the device will provide a simple way of letting them know. It will really empower HIV patients to keep a close eye on their health and their treatments."

Robin Weiss, Professor of Viral Oncology at UCL, whose pioneering work in identifying the receptor for HIV has deepened our understanding of HIV/AIDS, adds: "One of the principal advantages of the proposed device is its capacity to monitor viral and immunological markers on a single chip without the need for time consuming analysis that requires specialist laboratories."

Dr Yeong-Ah Soh, lecturer in Materials Science at Imperial, who is developing the fabrication methods needed to make the microcantilever arrays, adds:

"This project combines technology from semiconductor processing with modern biology to produce a unique piece of kit for tracking how HIV develops in individual patients, and helping them to keep a close eye on their own health"

The project will receive £2 million in funding over the next three years, with the promise of additional funding if the prototype device proves effective.

In the UK, there are an estimated 70,000 carriers of HIV. Worldwide, HIV/AIDS has grown to pandemic proportions and today there are 35 million people living with the virus, two-thirds of them in sub-Saharan Africa.


Grand Challenge Investigators:

LCN and UCL: Rachel McKendry (PI), Reader in Biomedical Nanoscience; Gabriel Aeppli, Quain Professor of Physics & co-Director of the LCN; Tom Duke, Professor of Physics LCN and Imperial College London: Yeong-ah Soh (PI), Lecturer in Materials Science; Tony Cass, Professor of Chemical Biology; Molly Stevens¬¬, Professor of Regenerative Medicine UCL/MRC Centre for Medical Molecular Virology, UCLH and Royal Free Hampstead NHS Trust: Deenan Pillay, Professor of Virology, Head of Dept of Infection & Honorary Consultant Medical Virologist; Anna Maria Geretti, Honorary Senior Lecturer & Consultant Medical Virologist; Robin Weiss, Professor of Viral Oncology; Vince Emery, Professor of Virology

####

About Imperial College London
Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 13,000 students and 6,000 staff of the highest international quality.

Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.

Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve health in the UK and globally, tackle climate change and develop clean and sustainable sources of energy.

For more information, please click here

Contacts:
Imperial College London, South Kensington Campus, London SW7 2AZ, tel: +44 (0)20 7589 5111

Copyright © Imperial College London

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

With a zap of light, system switches objects' colors and patterns: "Programmable matter" technique could enable product designers to churn out prototypes with ease May 6th, 2021

Polarization-sensitive photodetection using 2D/3D perovskite heterostructure crystal May 4th, 2021

Polarization-sensitive photodetection using 2D/3D perovskite heterostructure crystal May 4th, 2021

New Cypher VRS1250 Video-Rate Atomic Force Microscope Enables True Video-Rate Imaging at up to 45 Frames per Second April 30th, 2021

Investments/IPO's/Splits

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

180 Degree Capital Corp. to Report Fourth Quarter 2020 Financial Results on Monday, February 22, 2021 and to Host a Conference Call on Tuesday, February 23, 2021 February 19th, 2021

Nanomedicine

World's first fiber-optic ultrasonic imaging probe for future nanoscale disease diagnostics April 30th, 2021

Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease April 28th, 2021

Silver ions hurry up, then wait as they disperse: Rice chemists show ions’ staged release from gold-silver nanoparticles could be useful property April 23rd, 2021

Synthetic gelatin-like material mimics lobster underbelly’s stretch and strength: The membrane’s structure could provide a blueprint for robust artificial tissues April 23rd, 2021

Sensors

Polarization-sensitive photodetection using 2D/3D perovskite heterostructure crystal May 4th, 2021

Polarization-sensitive photodetection using 2D/3D perovskite heterostructure crystal May 4th, 2021

Researchers realize high-efficiency frequency conversion on integrated photonic chip April 23rd, 2021

Wearable sensors that detect gas leaks April 19th, 2021

Nanoelectronics

New tech builds ultralow-loss integrated photonic circuits April 16th, 2021

Graphene: Everything under control: Research team demonstrates control mechanism for quantum material April 9th, 2021

Energy transmission by gold nanoparticles coupled to DNA structures April 9th, 2021

Oxygen-promoted synthesis of armchair graphene nanoribbons on Cu(111) April 2nd, 2021

Announcements

With a zap of light, system switches objects' colors and patterns: "Programmable matter" technique could enable product designers to churn out prototypes with ease May 6th, 2021

Polarization-sensitive photodetection using 2D/3D perovskite heterostructure crystal May 4th, 2021

Polarization-sensitive photodetection using 2D/3D perovskite heterostructure crystal May 4th, 2021

New Cypher VRS1250 Video-Rate Atomic Force Microscope Enables True Video-Rate Imaging at up to 45 Frames per Second April 30th, 2021

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

New brain-like computing device simulates human learning: Researchers conditioned device to learn by association, like Pavlov's dog April 30th, 2021

Silver ions hurry up, then wait as they disperse: Rice chemists show ions’ staged release from gold-silver nanoparticles could be useful property April 23rd, 2021

Controlling bubble formation on electrodes: Study finds the wettability of porous electrode surfaces is key to making efficient water-splitting or carbon-capturing systems March 26th, 2021

Building tough 3D nanomaterials with DNA: Columbia Engineers use DNA nanotechnology to create highly resilient synthetic nanoparticle-based materials that can be processed through conventional nanofabrication methods March 19th, 2021

Nanobiotechnology

Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease April 28th, 2021

Synthetic gelatin-like material mimics lobster underbelly’s stretch and strength: The membrane’s structure could provide a blueprint for robust artificial tissues April 23rd, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project